[New biochemical and genetic risk factors for coronary artery diseases].
Imai
Yasushi
Y
Department of Cardiovascular Medicine and Clinical Bioinformatics, Graduate School of Medicine, University of Tokyo.
Nagai
Ryozo
R
D043303:Aryldialkylphosphatase; D015415:Biomarkers; D001779:Blood Coagulation Factors / Q000235:genetics; D002097:C-Reactive Protein; D008076:Cholesterol, HDL / Q000378:metabolism; D003324:Coronary Artery Disease / Q000209:etiology* / Q000235:genetics; D004950:Esterases / Q000235:genetics; D005340:Fibrinogen; D006710:Homocysteine; D006801:Humans; D007333:Insulin Resistance; D017270:Lipoprotein(a); D008077:Lipoproteins, LDL; D019001:Nitric Oxide Synthase / Q000235:genetics; D017395:Plasminogen Activator Inhibitor 1; D010980:Platelet Membrane Glycoproteins / Q000235:genetics; D011110:Polymorphism, Genetic; D012084:Renin-Angiotensin System / Q000235:genetics; D012307:Risk Factors
D015415:Biomarkers; D001779:Blood Coagulation Factors; D008076:Cholesterol, HDL; D017270:Lipoprotein(a); D008077:Lipoproteins, LDL; D017395:Plasminogen Activator Inhibitor 1; D010980:Platelet Membrane Glycoproteins; C099252:oxidized low density lipoprotein; D006710:Homocysteine; D005340:Fibrinogen; D002097:C-Reactive Protein; D019001:Nitric Oxide Synthase; D004950:Esterases; D043303:Aryldialkylphosphatase